SCHOTT Pharma AG KGaA Total Liabilities

SCHOTT Pharma AG KGaA (1SXP.F) currently reports a total liabilities of $700M as of June 2026. That compares with $660M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore SCHOTT Pharma AG KGaA's total liabilities history and peer comparisons.

SCHOTT Pharma AG KGaA's total liabilities increased from $660M to $700M — a 5.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SCHOTT Pharma AG KGaA reported $700M in total liabilities as of June 2026. That compares with $660M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $700M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SCHOTT Pharma AG KGaA, and consider following 1SXP.F for alerts when major investors trade the stock.